This chart shows the drugs with the most patents in Colombia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Colomb…
Which pharmaceutical drugs have the most drug patents in Colombia? Read Post »
This chart shows the drugs with the most patents in Colombia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Colomb…
Which pharmaceutical drugs have the most drug patents in Colombia? Read Post »
Annual Drug Patent Expirations for XYWAV Xywav is a drug marketed by Jazz and is included in one NDA. It is available from one supplier. There are eleven patents protecting…
The post New patent for JAZZ drug XYWAV appeared first on DrugPatentWatch – Ma…
Annual Drug Patent Expirations for ICLUSIG Iclusig is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There are five…
The post New patent for Takeda Pharms drug ICLUSIG appeared first on DrugPatentWat…
This chart shows the pharmaceutical companies with the most patents in Poland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug paten…
Which pharmaceutical companies have the most drug patents in Poland? Read Post »
Annual Drug Patent Expirations for VIMPAT Vimpat is a drug marketed by Ucb Inc and is included in three NDAs. It is available from three suppliers. There is one patent…
The post New patent expiration for Ucb Inc drug VIMPAT appeared first on DrugPatent…
Annual Drug Patent Expirations for XYREM Xyrem is a drug marketed by Jazz Pharms and is included in one NDA. It is available from one supplier. There are seven patents…
The post New patent for Jazz Pharms drug XYREM appeared first on DrugPatentWatch – …
Annual Drug Patent Expirations for TECFIDERA Tecfidera is a drug marketed by Biogen Inc and is included in one NDA. It is available from two suppliers. There are eight patents…
The post New patent for Biogen Inc drug TECFIDERA appeared first on DrugPat…
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Finland. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical…
Which pharmaceutical companies have the most SPCs in Finland? Read Post »
Annual Drug Patent Expirations for OTIPRIO Otiprio is a drug marketed by Alk Abello and is included in one NDA. It is available from one supplier. There are six patents…
The post New patent for Alk Abello drug OTIPRIO appeared first on DrugPatentWatch …
Get new actionable insights and updates from BiotechBlog
